These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 7534916)
1. Microvascularity in benign prostatic hyperplasia. Deering RE; Bigler SA; Brown M; Brawer MK Prostate; 1995 Mar; 26(3):111-5. PubMed ID: 7534916 [TBL] [Abstract][Full Text] [Related]
2. Microvascularity in transition zone prostate tumors resembles normal prostatic tissue. van Niekerk CG; Witjes JA; Barentsz JO; van der Laak JA; Hulsbergen-van de Kaa CA Prostate; 2013 Apr; 73(5):467-75. PubMed ID: 22996830 [TBL] [Abstract][Full Text] [Related]
3. Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer. Sinha AA; Quast BJ; Reddy PK; Lall V; Wilson MJ; Qian J; Bostwick DG Exp Mol Pathol; 2004 Oct; 77(2):153-9. PubMed ID: 15351240 [TBL] [Abstract][Full Text] [Related]
4. Topography of neovascularity in human prostate carcinoma. Siegal JA; Yu E; Brawer MK Cancer; 1995 May; 75(10):2545-51. PubMed ID: 7537624 [TBL] [Abstract][Full Text] [Related]
5. Cathepsin B in angiogenesis of human prostate: an immunohistochemical and immunoelectron microscopic analysis. Sinha AA; Gleason DF; Staley NA; Wilson MJ; Sameni M; Sloane BF Anat Rec; 1995 Mar; 241(3):353-62. PubMed ID: 7538734 [TBL] [Abstract][Full Text] [Related]
6. Should the diagnosis of benign prostatic hyperplasia be made on prostate needle biopsy? Viglione MP; Potter S; Partin AW; Lesniak MS; Epstein JI Hum Pathol; 2002 Aug; 33(8):796-800. PubMed ID: 12203211 [TBL] [Abstract][Full Text] [Related]
7. Limitations of transition zone needle biopsy findings in the prediction of transition zone cancer and tissue composition of benign nodular hyperplasia. McNeal J; Noldus J Urology; 1996 Nov; 48(5):751-6. PubMed ID: 8911519 [TBL] [Abstract][Full Text] [Related]
8. Decreased suburethral prostatic microvessel density in finasteride treated prostates: a possible mechanism for reduced bleeding in benign prostatic hyperplasia. Hochberg DA; Basillote JB; Armenakas NA; Vasovic L; Shevchuk M; Pareek G; Fracchia JA J Urol; 2002 Apr; 167(4):1731-3. PubMed ID: 11912398 [TBL] [Abstract][Full Text] [Related]
9. Is one single prostate biopsy helpful for choosing a medical treatment of benign prostatic hyperplasia? A quantitative computerized morphometric study. Zlota Ar; Sattar AA; Wespes E; Noel JC; Schulman CC Urology; 1996 Mar; 47(3):329-34. PubMed ID: 8633397 [TBL] [Abstract][Full Text] [Related]
10. Assessing the vascular-stromal coefficient in patients with benign prostatic hyperplasia or prostate cancer using transrectal ultrasonography and power Doppler analysis. Dobrowolski Z; Jaszczynski J; Drewniak T; Habrat W BJU Int; 2002 Apr; 89(6):601-3. PubMed ID: 11942973 [TBL] [Abstract][Full Text] [Related]
11. Stromal nodules in benign prostatic hyperplasia. Bierhoff E; Vogel J; Benz M; Giefer T; Wernert N; Pfeifer U Eur Urol; 1996; 29(3):345-54. PubMed ID: 8740022 [TBL] [Abstract][Full Text] [Related]
12. Comparison of microscopic vascularity in benign and malignant prostate tissue. Bigler SA; Deering RE; Brawer MK Hum Pathol; 1993 Feb; 24(2):220-6. PubMed ID: 8432518 [TBL] [Abstract][Full Text] [Related]
13. Relationship between the prostatic tissue components and natural history of benign prostatic hyperplasia. Matsuda T; Fujime M; Suda K Anal Quant Cytol Histol; 2006 Jun; 28(3):121-4. PubMed ID: 16786720 [TBL] [Abstract][Full Text] [Related]
14. Detection of prostate cancer and changes in prostate-specific antigen (PSA) six months after surgery for benign prostatic hyperplasia in patients with elevated PSA. Ozden C; Inal G; Adsan O; Yazici S; Ozturk B; Cetinkaya M Urol Int; 2003; 71(2):150-3. PubMed ID: 12890951 [TBL] [Abstract][Full Text] [Related]
15. Lymphatic vessel density in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer assessed in whole-mount sections. Longatto-Filho A; Malheiro LF; Milanezi F; Pinheiro C; Baltazar F; Schmitt FC; Montironi R Anal Quant Cytol Histol; 2009 Oct; 31(5):269-75. PubMed ID: 20701093 [TBL] [Abstract][Full Text] [Related]
16. Quantitative morphometric analysis of the microcirculation in prostate carcinoma. Brawer MK; Bigler SA; Deering RE J Cell Biochem Suppl; 1992; 16H():62-4. PubMed ID: 1283896 [TBL] [Abstract][Full Text] [Related]
17. "BPSA," a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasia. Mikolajczyk SD; Millar LS; Wang TJ; Rittenhouse HG; Wolfert RL; Marks LS; Song W; Wheeler TM; Slawin KM Urology; 2000 Jan; 55(1):41-5. PubMed ID: 10654892 [TBL] [Abstract][Full Text] [Related]
18. Calcitonin and calcitonin gene-related peptide in the human prostate gland. Abrahamsson PA; Dizeyi N; Alm P; di Sant'Agnese PA; Deftos LJ; Aumüller G Prostate; 2000 Aug; 44(3):181-6. PubMed ID: 10906733 [TBL] [Abstract][Full Text] [Related]
19. Relationship of neuroendocrine cells of prostate and serotonin to benign prostatic hyperplasia. Cockett AT; di Sant'Agnese PA; Gopinath P; Schoen SR; Abrahamsson PA Urology; 1993 Nov; 42(5):512-9. PubMed ID: 7694415 [TBL] [Abstract][Full Text] [Related]
20. Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1). Trojan L; Michel MS; Rensch F; Jackson DG; Alken P; Grobholz R J Urol; 2004 Jul; 172(1):103-7. PubMed ID: 15201747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]